CORCEPT THERAPEUTICS INC Restricted Cash
CORCEPT THERAPEUTICS INC (CORT) had Restricted Cash of $1.25 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2026-07-29
- 2026-06-30: Restricted Cash $1.25M.
- 2026-03-31: Restricted Cash $1.25M.
- 2025-06-30: Restricted Cash $1.00M.
- 2025-03-31: Restricted Cash $1.00M.
| Period end | Restricted Cash |
|---|---|
| 2026-06-30 | $1.25M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $1.25M 10-Q · filed 2026-04-30 |
| 2025-06-30 | $1.00M 10-Q · filed 2026-07-29 |
| 2025-03-31 | $1.00M 10-Q · filed 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |